RBPWorld - a comprehensive database of RNA Binding Proteins

Drugs target to POLE

Drug name	Drug type	Disease/phenotype	Mechanism of action(MoA)	Phase	Status	Source
CYTARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Suspended	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	myeloid neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	nodular sclerosis Hodgkin lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	Central Nervous System Neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	mycosis fungoides	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	hematopoietic and lymphoid cell neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	childhood acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	lymphoid neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
CLOFARABINE	Small molecule	lymphoblastic lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	hematopoietic and lymphoid cell neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	squamous cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Not yet recruiting	ClinicalTrials
GEMCITABINE	Small molecule	ovarian carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Suspended	ClinicalTrials
GEMCITABINE	Small molecule	fallopian tube cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
CYTARABINE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	uterine sarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	refractory anemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	kidney cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	adult acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	urinary bladder carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	neoplasm of mature B-cells	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	anxiety	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	bladder transitional cell carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	Mantle cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	childhood B acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Thalassemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Burkitts lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	melanoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	bladder transitional cell carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Sezary's disease	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	peritoneum cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	neuroblastoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	multiple myeloma	DNA polymerase (alpha/delta/epsilon) inhibitor	0.5	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	intrahepatic cholangiocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
CYTARABINE	Small molecule	acute leukemia of ambiguous lineage	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	central nervous system non-hodgkin lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	adult B acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	biliary tract cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	gallbladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	T-cell large granular lymphocyte leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	chronic lymphocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	systemic scleroderma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	melanoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	multiple myeloma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	cholangiocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	fallopian tube cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	primary peritoneal carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
CLOFARABINE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
CLOFARABINE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Waldenstrom macroglobulinemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	soft tissue sarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	Thromboembolism	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	T-cell acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	acute promyelocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	breast carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	-	DailyMed
GEMCITABINE HYDROCHLORIDE	Small molecule	cervical adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	ovarian cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	ovarian cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	hepatocellular carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
CLOFARABINE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	multiple myeloma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	kidney neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	Fallopian Tube Carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	cervical cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	ovarian cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	gastrointestinal stromal tumor	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	mixed phenotype acute leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	B-cell acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	unspecified peripheral T-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	unspecified peripheral T-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
CLOFARABINE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	lymphoid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	peritoneum cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	gastroesophageal junction adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	classic Hodgkin lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	follicular lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	mixed phenotype acute leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	chronic myelogenous leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	adult acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	systemic lupus erythematosus	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	lung cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	extranodal nasal NK/T cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	acute monocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
CLOFARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	malignant pleural mesothelioma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	acute myelomonocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	-	DailyMed
GEMCITABINE	Small molecule	testicular carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	cholangiocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Aplastic anemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	lymphoblastic lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	gallbladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	lung cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	lymphoblastic lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	neutropenia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	fallopian tube cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	fallopian tube cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	gastrointestinal stromal tumor	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	metastatic malignant neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute monocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	cholangiocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	cervical cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	biliary tract cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	biliary tract cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	severe combined immunodeficiency	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CLOFARABINE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	-	DailyMed
GEMCITABINE	Small molecule	breast carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	chronic myelogenous leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	metastatic melanoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	biliary tract neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	anemia (phenotype)	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
CLOFARABINE	Small molecule	adult acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	beta-thalassemia major	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
CLOFARABINE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	renal cell carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	sarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	ovarian carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	multiple myeloma	DNA polymerase (alpha/delta/epsilon) inhibitor	0.5	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	medulloblastoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
CYTARABINE	Small molecule	polycythemia vera	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	myeloproliferative disorder	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	cholangiocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	vasculitis	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	urinary bladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	cervical cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Not yet recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	immune system disease	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic ductal adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	nasopharyngeal neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	nodular sclerosis Hodgkin lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	lymphoblastic lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	neoplasm of mature B-cells	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute myelomonocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	-	ATC
GEMCITABINE	Small molecule	neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic ductal adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Suspended	ClinicalTrials
GEMCITABINE	Small molecule	biliary tract neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Digestive System Carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Mantle cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	0.5	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	hematopoietic and lymphoid cell neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	high grade B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	squamous cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	ovarian carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	-	DailyMed
FLUDARABINE PHOSPHATE	Small molecule	multiple myeloma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	lymphoid neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	skin cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	urinary bladder carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	primary peritoneal carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
CYTARABINE	Small molecule	melanoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	multiple myeloma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	aseptic meningitis	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	adult acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	0.5	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	Cutaneous T-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	lymphoid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	-	DailyMed
GEMCITABINE HYDROCHLORIDE	Small molecule	pancreatic adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Hepatoblastoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	gallbladder carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	cervical cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	biliary tract cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Not yet recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	prostate cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	renal pelvis/ureter urothelial carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	mixed phenotype acute leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	osteosarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	chronic myeloproliferative disorder	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	medulloblastoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	urogenital neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acquired aplastic anemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	urothelial carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Not yet recruiting	ClinicalTrials
GEMCITABINE	Small molecule	peritoneal neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	chronic granulomatous disease	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	T-cell acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
CLOFARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	melanoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	multiple myeloma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	cervical squamous cell carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	Vulvar Squamous Cell Carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	epidermolysis bullosa	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	peritoneal neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	core binding factor acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	urinary bladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Suspended	ClinicalTrials
GEMCITABINE	Small molecule	urethra cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	gallbladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	squamous cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	mycosis fungoides	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	peritoneum cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	infiltrating bladder urothelial carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	polycythemia vera	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	urothelial carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	mycosis fungoides	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
CYTARABINE	Small molecule	Mantle cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	Mantle cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	hematopoietic and lymphoid system neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	renal pelvis/ureter urothelial carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CLOFARABINE	Small molecule	Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	unspecified peripheral T-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	nasopharyngeal neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Not yet recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	kidney failure	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Immunodeficiency	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	gastric cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	ovarian cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	myelofibrosis	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Not yet recruiting	ClinicalTrials
GEMCITABINE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Juvenile Myelomonocytic Leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	mycosis fungoides	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	intrahepatic cholangiocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Withdrawn	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	ureter urothelial carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Fanconi anemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	metastatic malignant neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	chronic lymphocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	ovarian serous cystadenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	epidermolysis bullosa	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	colorectal carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	urinary bladder carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	ovarian cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	prostate cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
TROXACITABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	bladder tumor	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	primary myelofibrosis	DNA polymerase (alpha/delta/epsilon) inhibitor	0.5	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	nodular sclerosis Hodgkin lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	plasma cell leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	chronic myelomonocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	prolymphocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	adult acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	T-cell non-Hodgkin lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	post-transplant lymphoproliferative disease	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	unspecified peripheral T-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Enrolling by invitation	ClinicalTrials
GEMCITABINE	Small molecule	cholangiocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	intrahepatic cholangiocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	lymphoblastic lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	urethra cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	neoplasm of mature B-cells	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	Opsoclonus-Myoclonus Syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
CLOFARABINE	Small molecule	chronic myelomonocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	intrahepatic cholangiocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Not yet recruiting	ClinicalTrials
GEMCITABINE	Small molecule	follicular lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	hematopoietic and lymphoid cell neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Not yet recruiting	ClinicalTrials
GEMCITABINE	Small molecule	Endometrial Clear Cell Adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	urethra cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	cholangiocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	liver lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Not yet recruiting	ClinicalTrials
GEMCITABINE	Small molecule	adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	testicular carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	cholangiocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	hilar cholangiocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	peritoneum cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	ureter cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	lung cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	sickle cell anemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	metastatic malignant neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Not yet recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	neoplasm of mature B-cells	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	multiple myeloma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	peritoneum cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	0.5	Completed	ClinicalTrials
GEMCITABINE	Small molecule	hepatocellular carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	multiple myeloma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	relapsing-remitting multiple sclerosis	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	lung cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	classic Hodgkin lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	sickle cell anemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	nodal marginal zone B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	unspecified peripheral T-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Active, not recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	breast carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CLOFARABINE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	androgenetic alopecia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	lymphoid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	hairy cell leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	intrahepatic cholangiocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Not yet recruiting	ClinicalTrials
GEMCITABINE	Small molecule	biliary tract cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	sarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	Mantle cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	Mantle cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	melanoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	biliary tract neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Enrolling by invitation	ClinicalTrials
CYTARABINE	Small molecule	myeloproliferative disorder	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute erythroblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	peritoneum cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
CLOFARABINE	Small molecule	T-cell non-Hodgkin lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	extranodal nasal NK/T cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	T-lymphoblastic lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	osteosarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	brain neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	cholangiocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	head and neck malignant neoplasia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	lymphoblastic lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	adult acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	ovarian cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	ovarian cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	intrahepatic cholangiocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute erythroleukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	glioblastoma multiforme	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	lymphoid neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Not yet recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	metastatic melanoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	refractory anemia with excess blasts	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	urogenital neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	gallbladder neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CLOFARABINE	Small molecule	Langerhans Cell Histiocytosis	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	Malignant Pancreatic Neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Mantle cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	brain cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	renal pelvis/ureter urothelial carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	B-cell acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
CLOFARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	bladder tumor	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	breast carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	-	DailyMed
GEMCITABINE	Small molecule	carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Not yet recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	cervical carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	ovarian carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	metastatic melanoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	T-Cell Prolymphocytic Leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	Mantle cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	liver cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
CYTARABINE	Small molecule	childhood acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	sarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	cervical carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	metastatic melanoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	biliary tract neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Not yet recruiting	ClinicalTrials
GEMCITABINE	Small molecule	intrahepatic cholangiocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	cervical cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	urethra cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
CLOFARABINE	Small molecule	myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	refractory anemia with ringed sideroblasts	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	biliary tract neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	Endometrial Clear Cell Adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	Granulocytic Sarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	urinary bladder carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	metastatic malignant neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	systemic scleroderma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	cervical carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	medulloblastoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	gallbladder neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	uterine leiomyosarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	mature T-cell and NK-cell non-Hodgkin lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Not yet recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	urethra cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	follicular lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Fanconi anemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	T-cell acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	0.5	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	acute promyelocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	renal cell carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	multiple myeloma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	primary myelofibrosis	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	osteoporosis	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	urothelial carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
CLOFARABINE	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	hematopoietic and lymphoid cell neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Suspended	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	-	ATC
GEMCITABINE	Small molecule	small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic ductal adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	urinary bladder carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Not yet recruiting	ClinicalTrials
CYTARABINE	Small molecule	neoplasm of mature B-cells	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Suspended	ClinicalTrials
CYTARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	0.5	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	acute promyelocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic ductal adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	anaplastic large cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	severe aplastic anemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	urinary bladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	urethra cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	acute promyelocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	neuroblastoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Aplastic anemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	liver cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	myelodysplastic/myeloproliferative disease	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	metastatic malignant neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Sezary's disease	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	metastatic colorectal cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	ovarian mucinous cystadenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	urinary bladder carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Not yet recruiting	ClinicalTrials
GEMCITABINE	Small molecule	breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	lung cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic ductal adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Not yet recruiting	ClinicalTrials
CYTARABINE	Small molecule	overactive bladder	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	chronic myelomonocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	ovarian cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	-	DailyMed
FLUDARABINE PHOSPHATE	Small molecule	graft versus host disease	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	0.5	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	diffuse intrinsic pontine glioma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	ovarian cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	0.5	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	sickle cell anemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	sickle cell anemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	chronic lymphocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Not yet recruiting	ClinicalTrials
GEMCITABINE	Small molecule	leiomyosarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Suspended	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	embryonal neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Brain Stem Glioma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	aseptic meningitis	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Immunodeficiency	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	gastric cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	graft versus host disease	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	follicular lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	bladder tumor	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	mesothelioma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	primary myelofibrosis	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	nasopharyngeal neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	0.5	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	0.5	Completed	ClinicalTrials
CYTARABINE	Small molecule	acute erythroblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
CYTARABINE	Small molecule	Lymphoma, AIDS-Related	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	prostate cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	myelofibrosis	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	nasopharyngeal neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	Mantle cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	chronic myelomonocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	fallopian tube cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	head and neck squamous cell carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	melanoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	metastatic melanoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	uterine sarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	leptomeningeal metastasis	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	-	DailyMed
GEMCITABINE	Small molecule	urinary bladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	ureter cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	sickle cell anemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute erythroleukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	mesothelioma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Not yet recruiting	ClinicalTrials
GEMCITABINE	Small molecule	ovarian neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	plasma cell leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	renal pelvis/ureter urothelial carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	sarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	metastatic melanoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	colorectal cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	soft tissue sarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	peritoneum cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	urinary bladder carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	ovarian cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	follicular lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	metastatic malignant neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	0.5	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	cutaneous melanoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	multiple myeloma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	colorectal carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	kidney cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	neoplasm of mature B-cells	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	bladder tumor	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Aplastic anemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	prolymphocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	ovarian cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	extranodal nasal NK/T cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute megakaryoblastic leukaemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	nasopharyngeal neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Not yet recruiting	ClinicalTrials
GEMCITABINE	Small molecule	bladder transitional cell carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	Mantle cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	nodal marginal zone B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	adult T-cell leukemia/lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
ASPACYTARABINE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	cutaneous melanoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic ductal adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	psoriatic arthritis	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	nasopharyngeal neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	urinary bladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	ovarian cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	lung cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Not yet recruiting	ClinicalTrials
CYTARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Withdrawn	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	head and neck malignant neoplasia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Juvenile Myelomonocytic Leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Uveal Melanoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Wiskott-Aldrich syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	high grade B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
CLOFARABINE	Small molecule	Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
CLOFARABINE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	squamous cell carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	breast neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	myeloproliferative disorder	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	Fallopian Tube Carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	Mantle cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	adult acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	kidney cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	immune deficiency disease	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	metastatic malignant neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	-	FDA
FLUDARABINE PHOSPHATE	Small molecule	clear cell renal carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	myelofibrosis	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	hepatocellular carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
CYTARABINE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	multiple myeloma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Suspended	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	lymphoid neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	myeloproliferative disorder	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	ovarian leiomyosarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	urinary bladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Not yet recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	kidney cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	ovarian cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	prostate cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	MALT lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	bone marrow failure syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	cervical cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	ovarian cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	neoplasm of mature B-cells	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Not yet recruiting	ClinicalTrials
GEMCITABINE	Small molecule	breast carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	childhood acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	peritoneum cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	fallopian tube cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	graft versus host disease	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	lung cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	chronic granulomatous disease	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	neoplasm of mature B-cells	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Crohn's disease	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
TROXACITABINE	Small molecule	neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	multiple myeloma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	multiple myeloma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	chronic myeloproliferative disorder	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	breast neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	lymphoid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	Mantle cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	lymphoblastic lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
CLOFARABINE	Small molecule	graft versus host disease	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	malignant epithelial tumor of ovary	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	lung neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	Ewing sarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CLOFARABINE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	childhood acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	0.5	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic ductal adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	bladder transitional cell carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	urothelial carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	intrahepatic cholangiocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	fallopian tube cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	B-cell acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Not yet recruiting	ClinicalTrials
GEMCITABINE	Small molecule	anaplastic large cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute graft vs. host disease	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	head and neck malignant neoplasia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	fallopian tube cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	ovarian cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	follicular lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	renal pelvis/ureter urothelial carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Burkitts lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	Burkitts lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	glioblastoma multiforme	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	multiple myeloma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	pancreatic ductal adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	urogenital neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	Lymphoma, AIDS-Related	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	ovarian cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	lung cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	lymphoproliferative syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	follicular lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
CLOFARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	bladder tumor	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	uterine neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	primary peritoneal carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	central nervous system non-hodgkin lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	high grade B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	Ewing sarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	ovarian neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	gallbladder neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	triple-negative breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	severe aplastic anemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Myelodysplastic/Myeloproliferative Neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	kidney cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	severe combined immunodeficiency	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
CYTARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	uterine neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	cervical squamous cell carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	urinary bladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	fallopian tube cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	ovarian cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	-	DailyMed
CYTARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	-	DailyMed
GEMCITABINE	Small molecule	pancreatic neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	cholangiocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	urinary bladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	kidney cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	-	DailyMed
GEMCITABINE	Small molecule	ovarian cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	lung neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CLOFARABINE	Small molecule	myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Not yet recruiting	ClinicalTrials
CYTARABINE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	malaria	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	nasopharyngeal neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	urothelial carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	pancreatic adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	rectum cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	hepatosplenic T-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	renal pelvis/ureter urothelial carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	combined hepatocellular carcinoma and cholangiocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	hematopoietic and lymphoid cell neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	cutaneous melanoma	DNA polymerase (alpha/delta/epsilon) inhibitor	0.5	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	melanoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Not yet recruiting	ClinicalTrials
GEMCITABINE	Small molecule	nasopharyngeal neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	metastasis	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	Kidney Medullary Carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	childhood B acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	prostate cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	multiple myeloma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	acute myeloblastic leukemia without maturation	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	urothelial carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
CLOFARABINE	Small molecule	chronic lymphocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	breast carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	ovarian neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	metastasis	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Central Nervous System Lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Not yet recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Mantle cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	neoplasm of mature B-cells	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	unspecified peripheral T-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
CLOFARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
CLOFARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	multiple myeloma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	cholangiocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
CYTARABINE	Small molecule	high grade B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	childhood acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	head and neck malignant neoplasia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
CLOFARABINE	Small molecule	Langerhans Cell Histiocytosis	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Mantle cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Histiocytosis	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	bladder tumor	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	chronic myelogenous leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute megakaryoblastic leukaemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute graft vs. host disease	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	head and neck malignant neoplasia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	urinary bladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	urinary bladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	infiltrating bladder urothelial carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	esophageal cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	ovarian cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	immune deficiency disease	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	Hereditary breast and ovarian cancer syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	breast neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	head and neck malignant neoplasia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	central nervous system germ cell tumor	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	primary peritoneal carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Beta-thalassemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	neoplasm of mature B-cells	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
CLOFARABINE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	Kidney Medullary Carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	myeloid sarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Aplastic anemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	kidney cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	lung cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	malignant colon neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	sarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	cervical carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
CLOFARABINE	Small molecule	multiple myeloma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	anaplastic large cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	lung cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	renal pelvis/ureter urothelial carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
ASPACYTARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Terminated	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	Fallopian Tube Carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	primary peritoneal carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	lung neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	-	DailyMed
GEMCITABINE	Small molecule	carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	cutaneous melanoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Juvenile Myelomonocytic Leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	peritoneal neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	colorectal carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	urethra cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	sarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	cholangiocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	peritoneum cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	cutaneous melanoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	lung adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	neuroblastoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
CYTARABINE	Small molecule	childhood T acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	colorectal carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	neoplasm of mature B-cells	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	leiomyosarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	liver cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	nasopharyngeal type undifferentiated carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	gallbladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Not yet recruiting	ClinicalTrials
GEMCITABINE	Small molecule	ovarian cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	severe combined immunodeficiency	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
CLOFARABINE	Small molecule	myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	osteosarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	renal cell carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	biliary tract neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Not yet recruiting	ClinicalTrials
CYTARABINE	Small molecule	adult B acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	uterine leiomyosarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	prostate cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	0.5	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	myelofibrosis	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	0.5	Not yet recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	bladder tumor	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	-	ATC
FLUDARABINE PHOSPHATE	Small molecule	lymphoid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	metastatic neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	pancreatic adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	soft tissue sarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	chronic lymphocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	neoplasm of mature B-cells	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	cutaneous melanoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	glioblastoma multiforme	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	soft tissue sarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	lymphoblastic lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	essential thrombocythemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
CLOFARABINE	Small molecule	neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	-	ATC
GEMCITABINE	Small molecule	osteosarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic ductal adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	urinary bladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	congenital amegakaryocytic thrombocytopenia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	primary peritoneal carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	primary peritoneal carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Not yet recruiting	ClinicalTrials
CYTARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	cutaneous melanoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	myeloproliferative disorder	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	head and neck malignant neoplasia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	T-cell non-Hodgkin lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	unspecified peripheral T-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	acute monocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
ASPACYTARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CLOFARABINE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	squamous cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	metastatic melanoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	Digestive System Carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CLOFARABINE	Small molecule	Langerhans Cell Histiocytosis	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	childhood acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	lymphoblastic lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	urinary bladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
CLOFARABINE	Small molecule	cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
CLOFARABINE	Small molecule	myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	ovarian carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	-	DailyMed
CYTARABINE	Small molecule	refractory anemia with ringed sideroblasts	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Mantle cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	hepatocellular carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	hematologic disease	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	severe aplastic anemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Not yet recruiting	ClinicalTrials
GEMCITABINE	Small molecule	endometrial adenosquamous carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	kidney cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	urethra cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	lung cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	T-cell non-Hodgkin lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic ductal adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Not yet recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	anemia (phenotype)	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	urinary bladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	primary peritoneal carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	mesothelioma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	multiple myeloma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Not yet recruiting	ClinicalTrials
CYTARABINE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	chronic inflammatory demyelinating polyneuropathy	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	chronic myelomonocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	primary peritoneal carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	B-cell acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	unspecified peripheral T-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	meningeal neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	bladder transitional cell carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	gallbladder carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	urinary bladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	kidney cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	urethra cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	endometrial cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	lymphoid neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	biliary tract disease	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	chronic myelomonocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	malignant pleural mesothelioma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	diffuse intrinsic pontine glioma	DNA polymerase (alpha/delta/epsilon) inhibitor	0.5	Withdrawn	ClinicalTrials
CYTARABINE	Small molecule	Central Nervous System Lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	Fallopian Tube Carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	Juvenile Myelomonocytic Leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	B-cell non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	Richter syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	malignant tumor of extrahepatic bile duct	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Beta-thalassemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	chronic lymphocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
TROXACITABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	breast adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Langerhans Cell Histiocytosis	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Sezary's disease	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	esophageal cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	nodal marginal zone B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	central nervous system non-hodgkin lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	acute promyelocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	chronic myelogenous leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	multiple myeloma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	refractory anemia with excess blasts	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	male breast carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	urothelial carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	uterine leiomyosarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Suspended	ClinicalTrials
GEMCITABINE	Small molecule	breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	hematopoietic and lymphoid cell neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	ovarian carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	multiple myeloma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	urinary bladder carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	gallbladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	endometrial cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	graft versus host disease	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Not yet recruiting	ClinicalTrials
CYTARABINE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Withdrawn	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	bladder transitional cell carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	bladder transitional cell carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	gastric cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	extranodal nasal NK/T cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Crohn's disease	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	glioblastoma multiforme	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Not yet recruiting	ClinicalTrials
GEMCITABINE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	multiple myeloma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	adult B acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	0.5	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	urinary bladder carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	malignant epithelial tumor of ovary	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	nongerminomatous germ cell tumor	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Not yet recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
CLOFARABINE	Small molecule	acute promyelocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	bladder tumor	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic ductal adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Terminated	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	endometrial adenosquamous carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	chronic lymphocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Not yet recruiting	ClinicalTrials
CYTARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	renal cell carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	urinary bladder carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	metastatic melanoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	bladder transitional cell carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	toxicity	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	pancreatic adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
CLOFARABINE	Small molecule	cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	classic Hodgkin lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	chronic myelogenous leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Waldenstrom macroglobulinemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	lung cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	lung cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	hematopoietic and lymphoid cell neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	chronic lymphocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	lung adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	squamous cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	blastic plasmacytoid dendritic cell neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	thyroid cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Shwachman-Diamond syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	pancreatic ductal adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	plasmacytoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	follicular lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	high grade B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Not yet recruiting	ClinicalTrials
CLOFARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Thalassemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	Thromboembolism	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	brain cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	medullary thyroid gland carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	primary peritoneal carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
CLOFARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	sarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic ductal adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	bladder transitional cell carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	mature T-cell and NK-cell non-Hodgkin lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	childhood acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	urinary bladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	multiple sclerosis	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	precursor B-cell acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	Burkitts lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic ductal adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	urothelial carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	gastroesophageal junction adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	urethra cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
CLOFARABINE	Small molecule	osteopetrosis	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	acute monocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Not yet recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	0.5	Not yet recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	childhood T acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	biliary tract cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	ovarian cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	adult T-cell leukemia/lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	childhood acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	metastatic melanoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	acute myeloblastic leukemia with maturation	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	plasma cell leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	urothelial carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	osteopetrosis	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
CLOFARABINE	Small molecule	myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Burkitts lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	Burkitts lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	chronic myelogenous leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Not yet recruiting	ClinicalTrials
GEMCITABINE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	large cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	gastrointestinal disease	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	kidney cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	biliary tract cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	gallbladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	lung cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	Hereditary breast and ovarian cancer syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	B-cell acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	skin cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	melanoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	colorectal carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Pure red cell aplasia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	fallopian tube cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	head and neck squamous cell carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	melanoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	plasma cell leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	0.5	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Ocular Melanoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	childhood B acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	adult acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	angioimmunoblastic T-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	central nervous system cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Not yet recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	childhood acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
CYTARABINE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	triple-negative breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	pancreatic adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	pancreatic adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	rectum cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	intrahepatic cholangiocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	ovarian cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	lung cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	acute leukemia of ambiguous lineage	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	paroxysmal nocturnal hemoglobinuria	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	germ cell tumor	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	renal cell carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	overactive bladder	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	soft tissue sarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	gallbladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	lung cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	neoplasm of mature B-cells	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	metastatic melanoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	refractory anemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	cholangiocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Not yet recruiting	ClinicalTrials
CLOFARABINE	Small molecule	hematologic disease	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	plasma cell leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	skin cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	biliary tract cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	chronic lymphocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Suspended	ClinicalTrials
GEMCITABINE	Small molecule	carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	pancreatic adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	ureter urothelial carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	biliary tract cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	ovarian cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	lung neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	myeloproliferative disorder	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	testicular carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	urinary bladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	ovarian cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	nasopharyngeal neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	head and neck malignant neoplasia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	head and neck malignant neoplasia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	neuroblastoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	pancreatic ductal adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CLOFARABINE	Small molecule	chronic myelomonocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	lymphoblastic lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	peritoneum cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	malignant colon neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
CLOFARABINE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
CYTARABINE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
CLOFARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	nasopharyngeal neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	nasopharyngeal neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	hematologic disease	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	cervical cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	prostate cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	lung cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	chronic lymphocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	chronic myelogenous leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	melanoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	multiple myeloma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	metastatic melanoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	acute megakaryoblastic leukaemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	refractory anemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	urethra cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	sickle cell anemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	high grade B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	acute erythroleukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	mesothelioma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	multiple myeloma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	childhood acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	0.5	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Shwachman-Diamond syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	follicular lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	neoplasm of mature B-cells	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Suspended	ClinicalTrials
CLOFARABINE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	rheumatoid arthritis	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	melanoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	malignant pleural mesothelioma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	ovarian carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	neoplasm of mature T-cells or NK-cells	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	pancreatic ductal adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	plasmacytoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Mantle cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	Mantle cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	urinary bladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	adult acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	congenital amegakaryocytic thrombocytopenia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	renal pelvis/ureter urothelial carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	metastatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	chronic lymphocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	hepatocellular carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
CYTARABINE	Small molecule	myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	unspecified peripheral T-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	Langerhans Cell Histiocytosis	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	adult T acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	intrahepatic cholangiocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	biliary tract cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	B-cell acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	0.5	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Withdrawn	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	prolymphocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	esophageal cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	follicular lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	renal pelvis/ureter urothelial carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CLOFARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	endometrioid carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	mesothelioma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	ovarian carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	biliary tract neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	nasopharyngeal neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Diamond-Blackfan anemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	T-cell non-Hodgkin lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute leukemia of ambiguous lineage	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	bone sarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	sarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic ductal adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
CLOFARABINE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	severe aplastic anemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	blastic plasmacytoid dendritic cell neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	ovarian serous cystadenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	Fallopian Tube Carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
CLOFARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	Uterine Carcinosarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	metastatic colorectal cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	bladder tumor	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	nasopharyngeal neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Not yet recruiting	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Splenic Marginal Zone Lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	lung cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	classic Hodgkin lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic ductal adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	gallbladder carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	spinal cord glioma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	lung cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Withdrawn	ClinicalTrials
CYTARABINE	Small molecule	mixed phenotype acute leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	breast carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	cervical carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	ovarian carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	nasopharyngeal neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	childhood acute myeloid leukemia with maturation	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	esophageal cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	ovarian cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	lung cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	osteopetrosis	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	Mantle cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
CLOFARABINE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	systemic scleroderma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	adult T-cell leukemia/lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	renal pelvis/ureter urothelial carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	lung neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	neuroepithelial neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	0.5	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	unspecified peripheral T-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Enrolling by invitation	ClinicalTrials
CLOFARABINE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	myeloproliferative disorder	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	urinary bladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	biliary tract cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Not yet recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	triple-negative breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Not yet recruiting	ClinicalTrials
GEMCITABINE	Small molecule	Ovarian Carcinosarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	hilar cholangiocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
CYTARABINE	Small molecule	T-lymphoblastic lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
CLOFARABINE	Small molecule	neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	multiple myeloma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Not yet recruiting	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic ductal adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	chronic lymphocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	metastatic prostate cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	head and neck malignant neoplasia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	ovarian mucinous cystadenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	urinary bladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Suspended	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	adult T-cell leukemia/lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CLOFARABINE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	head and neck malignant neoplasia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	Stiff-Person syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	peritoneum cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	lung cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	nodular sclerosis Hodgkin lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Not yet recruiting	ClinicalTrials
GEMCITABINE	Small molecule	soft tissue sarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	lung cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	high grade B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	chronic lymphocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
CYTARABINE	Small molecule	Myasthenia gravis	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	childhood acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	ovarian cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	classic Hodgkin lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Not yet recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	follicular lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	chronic lymphocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Not yet recruiting	ClinicalTrials
ASPACYTARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	angioimmunoblastic T-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	renal cell carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	mycosis fungoides	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	gallbladder carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
CYTARABINE	Small molecule	graft versus host disease	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Not yet recruiting	ClinicalTrials
CYTARABINE	Small molecule	mixed phenotype acute leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	pancreatic ductal adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	endometrial cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	severe congenital neutropenia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	neoplasm of mature B-cells	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	squamous cell carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	male breast carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	peritoneum cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	biliary tract cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	-	DailyMed
GEMCITABINE HYDROCHLORIDE	Small molecule	lung cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	chronic myeloproliferative disorder	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	head and neck malignant neoplasia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	gliosarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	urinary bladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Not yet recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	liver cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	urinary bladder carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	hepatocellular carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	hepatocellular carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	unspecified peripheral T-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Not yet recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	chronic myelogenous leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	sarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	-	DailyMed
GEMCITABINE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	biliary tract neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Not yet recruiting	ClinicalTrials
GEMCITABINE	Small molecule	triple-negative breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	colorectal carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	bone marrow failure syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	0.5	Recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	fallopian tube cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	biliary tract cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	sickle cell anemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	chronic lymphocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	-	DailyMed,FDA
GEMCITABINE	Small molecule	Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	bladder transitional cell carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	childhood acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	biliary tract cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	acute leukemia of ambiguous lineage	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Not yet recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	mesothelioma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	multiple myeloma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CLOFARABINE	Small molecule	neoplasm of mature B-cells	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	nodular sclerosis Hodgkin lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	follicular lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	post-transplant lymphoproliferative disease	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	combined hepatocellular carcinoma and cholangiocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	B-cell acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	neuroblastoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Not yet recruiting	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic ductal adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Not yet recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute myeloblastic leukemia without maturation	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	biliary tract neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	fallopian tube cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
CYTARABINE	Small molecule	Parkinson disease	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	ovarian cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	prostate cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	metastatic malignant neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	chronic lymphocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	endometrioid carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	systemic scleroderma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	multiple myeloma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	lymphoblastic lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Richter syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	lung cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	urothelial carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Not yet recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	urinary bladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	urinary bladder carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	ureter cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
CYTARABINE	Small molecule	Central Nervous System Neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	intrahepatic cholangiocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Not yet recruiting	ClinicalTrials
GEMCITABINE	Small molecule	gallbladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	ovarian cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	hematopoietic and lymphoid cell neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	T-cell acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	breast carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	breast carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	lymphoid neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	chronic myeloproliferative disorder	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	diffuse intrinsic pontine glioma	DNA polymerase (alpha/delta/epsilon) inhibitor	0.5	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Mantle cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	childhood B acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	neuroblastoma	DNA polymerase (alpha/delta/epsilon) inhibitor	0.5	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	breast neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	bladder transitional cell carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	intrahepatic cholangiocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	T-cell large granular lymphocyte leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	acute promyelocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	renal cell carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	malignant pleural mesothelioma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	breast neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	urothelial carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	pancreatic adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	adult B acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	core binding factor acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	fallopian tube cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	cervical cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	follicular lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	nasopharyngeal neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	nasopharyngeal neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	bone marrow failure syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	urinary bladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	post-transplant lymphoproliferative disease	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Not yet recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Not yet recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	neuroblastoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	ovarian carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	Hepatoblastoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Mantle cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	childhood acute myeloid leukemia with maturation	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	hematopoietic and lymphoid cell neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	chronic lymphocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
CLOFARABINE	Small molecule	Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	childhood acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Suspended	ClinicalTrials
CYTARABINE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	cholangiocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	B-Cell Prolymphocytic Leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Splenic Marginal Zone Lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Mantle cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	fallopian tube cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute leukemia of ambiguous lineage	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	nodal marginal zone B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Suspended	ClinicalTrials
CLOFARABINE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	neuroblastoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	lymphoid neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	biliary tract neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	lupus nephritis	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	hepatocellular carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	childhood acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	ovarian carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	toxicity	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	overactive bladder	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	childhood T acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	adult acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Fanconi anemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	ovarian carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic ductal adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	uterine leiomyosarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	extranodal nasal NK/T cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	extranodal nasal NK/T cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	myelofibrosis	DNA polymerase (alpha/delta/epsilon) inhibitor	0.5	Completed	ClinicalTrials
CLOFARABINE	Small molecule	chronic lymphocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	hepatocellular carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	breast adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	multiple myeloma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	multiple myeloma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	bladder transitional cell carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	acute promyelocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
CLOFARABINE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	sarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	multiple myeloma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	lymphoid neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	triple-negative breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	thyroid cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	ovarian cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Not yet recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Fanconi anemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	chronic lymphocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
CLOFARABINE	Small molecule	neoplasm of mature B-cells	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CLOFARABINE	Small molecule	myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	chronic myelogenous leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
TROXACITABINE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	ovarian neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	childhood acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	sarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	malignant pleural mesothelioma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	malignant pleural mesothelioma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	ovarian neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	Ovarian Carcinosarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	peritoneal neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	chronic myelomonocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	mixed phenotype acute leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	high grade B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	esophageal adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic ductal adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	anaplastic large cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	renal pelvis carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Immunodeficiency	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	primary peritoneal carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	central nervous system non-hodgkin lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	neuroblastoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	sarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	neuromyelitis optica	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	urothelial carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	Langerhans Cell Histiocytosis	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	urethra cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Wiskott-Aldrich syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	renal pelvis/ureter urothelial carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	renal pelvis/ureter urothelial carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	chronic lymphocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	angioimmunoblastic T-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	colorectal adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Not yet recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	neuroblastoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	synovial sarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Suspended	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	peritoneum cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	gallbladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	chronic lymphocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	uterine leiomyosarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	bile duct cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Suspended	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Crohn's disease	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	lung adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Not yet recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	psoriasis	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	nasopharyngeal neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	nasopharyngeal neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	neuromyelitis optica	DNA polymerase (alpha/delta/epsilon) inhibitor	0.5	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	epidermolysis bullosa	DNA polymerase (alpha/delta/epsilon) inhibitor	0.5	Terminated	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	colorectal carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	soft tissue sarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	soft tissue sarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	urinary bladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	kidney cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
CLOFARABINE	Small molecule	mixed phenotype acute leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	neoplasm of mature B-cells	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Not yet recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Ewing sarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	diffuse large B-cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	cervical adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	bladder transitional cell carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Mantle cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	urinary bladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	liver cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic ductal adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	0.5	Unknown status	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
GEMCITABINE	Small molecule	intrahepatic cholangiocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Not yet recruiting	ClinicalTrials
CYTARABINE	Small molecule	lymphoblastic lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	urinary bladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	liver cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CLOFARABINE	Small molecule	chronic lymphocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
CLOFARABINE	Small molecule	acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	sarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	-	DailyMed
CYTARABINE	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	neoplasm of mature B-cells	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	chronic myelogenous leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	sarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Not yet recruiting	ClinicalTrials
GEMCITABINE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Not yet recruiting	ClinicalTrials
GEMCITABINE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	urinary bladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Withdrawn	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	graft versus host disease	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	chronic lymphocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE	Small molecule	small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	anaplastic large cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	breast neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	pancreatic adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	Mantle cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Unknown status	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	lung cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	malignant tumor of extrahepatic bile duct	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	paroxysmal nocturnal hemoglobinuria	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	T-cell acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	pancreatic carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Waldenstrom macroglobulinemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	systemic lupus erythematosus	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	lung cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	myelofibrosis	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	MALT lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
CLOFARABINE	Small molecule	chronic myelogenous leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	renal cell carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Withdrawn	ClinicalTrials
CYTARABINE	Small molecule	acute basophilic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Suspended	ClinicalTrials
GEMCITABINE	Small molecule	triple-negative breast cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	Uterine Carcinosarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	kidney cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	lymphoproliferative syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Unknown status	ClinicalTrials
CYTARABINE	Small molecule	acute leukemia of ambiguous lineage	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
CYTARABINE	Small molecule	T-cell acute lymphoblastic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	multiple myeloma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	primary myelofibrosis	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	pancreatic ductal adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Not yet recruiting	ClinicalTrials
GEMCITABINE	Small molecule	Fallopian Tube Carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	Fallopian Tube Carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	soft tissue sarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	skin cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Terminated	ClinicalTrials
CLOFARABINE	Small molecule	acute myeloid leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	osteosarcoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	renal cell carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	refractory anemia	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	nasopharyngeal neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
GEMCITABINE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	non-Hodgkins lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	ependymal neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Recruiting	ClinicalTrials
GEMCITABINE	Small molecule	Vulvar Squamous Cell Carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	Aplastic anemia	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Unknown status	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	urinary bladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	post-transplant lymphoproliferative disease	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	myelofibrosis	DNA polymerase (alpha/delta/epsilon) inhibitor	0.5	Completed	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	chronic lymphocytic leukemia	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
GEMCITABINE	Small molecule	lung adenocarcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Active, not recruiting	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	systemic scleroderma	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials
FLUDARABINE PHOSPHATE	Small molecule	anaplastic large cell lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Completed	ClinicalTrials
GEMCITABINE	Small molecule	non-small cell lung carcinoma	DNA polymerase (alpha/delta/epsilon) inhibitor	4.0	Not yet recruiting	ClinicalTrials
GEMCITABINE	Small molecule	nasopharyngeal neoplasm	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Active, not recruiting	ClinicalTrials
CYTARABINE	Small molecule	Central Nervous System Lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Recruiting	ClinicalTrials
CYTARABINE	Small molecule	lymphoblastic lymphoma	DNA polymerase (alpha/delta/epsilon) inhibitor	2.0	Not yet recruiting	ClinicalTrials
GEMCITABINE HYDROCHLORIDE	Small molecule	urinary bladder cancer	DNA polymerase (alpha/delta/epsilon) inhibitor	3.0	Completed	ClinicalTrials
CYTARABINE	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA polymerase (alpha/delta/epsilon) inhibitor	1.0	Terminated	ClinicalTrials

Welcome to

RBP World!

Drugs target to POLE

Targets details